Jenner B, Jones D, Kusinski L C, Patient C, Park A, Sarker A, Bansiya V, Gurnell E M, Meek C L
Department of Clinical Pharmacology and Therapeutics, Cambridge University NHS Foundation Trust, Cambridge, UK.
Institute of Metabolic Science Metabolic Research Laboratories, University of Cambridge, Cambridge, UK.
Clin Med (Lond). 2025 May;25(3):100318. doi: 10.1016/j.clinme.2025.100318. Epub 2025 Apr 29.
Pregnant women with previous bariatric surgery are at increased risk of gestational diabetes mellitus (GDM) but many cannot safely tolerate the oral glucose tolerance test (OGTT). Consensus recommendations advise self-monitoring of blood glucose (SMBG) for GDM diagnosis, but diagnostic thresholds are unexplored in this population.
To assess the incidence of SMBG-defined GDM (fasting, 1-hr postprandial thresholds: 90, 140 mg/dL (5.3, 7.8 mmol/L)) after bariatric surgery, compared to the incidence of OGTT-defined GDM in women with risk factors for GDM but no history of bariatric surgery.
Patients with a history of bariatric surgery (n=24) were included in a retrospective service evaluation based at a single tertiary referral centre in England, with results compared to a national study of women at high risk of GDM but without a history of bariatric surgery (n=1,308).
The incidence of GDM diagnosed according to SMBG vs OGTT.
GDM incidence was 16/24 (66.7%; SMBG-defined) after bariatric surgery and 121/1,308 (9.3%; OGTT-defined) in the control group, with the highest incidence rates seen after gastric bypass (85.7%). In women with previous bariatric surgery, HbA1c showed no association with GDM diagnosis, the requirement for treatment or offspring birth weight.
SMBG at standard thresholds is not able to reliably diagnose GDM after bariatric surgery and is likely to over-diagnose GDM, especially after gastric bypass, although small sample size limits generalisability of this study. Alternative diagnostic and prognostic markers are warranted for diagnosis of GDM after bariatric surgery.
既往接受过减肥手术的孕妇患妊娠期糖尿病(GDM)的风险增加,但许多人无法安全耐受口服葡萄糖耐量试验(OGTT)。共识性建议建议通过自我血糖监测(SMBG)来诊断GDM,但该人群的诊断阈值尚未得到研究。
评估减肥手术后通过SMBG定义的GDM(空腹、餐后1小时阈值:90、140mg/dL(5.3、7.8mmol/L))的发生率,并与有GDM风险因素但无减肥手术史的女性中通过OGTT定义的GDM的发生率进行比较。
有减肥手术史的患者(n=24)纳入了一项基于英国一家单一三级转诊中心的回顾性服务评估,结果与一项针对有GDM高风险但无减肥手术史的女性的全国性研究(n=1308)进行比较。
根据SMBG与OGTT诊断的GDM的发生率。
减肥手术后GDM的发生率为16/24(66.7%;SMBG定义),对照组为121/1308(9.3%;OGTT定义),胃旁路术后的发生率最高(85.7%)。在既往有减肥手术史的女性中,糖化血红蛋白(HbA1c)与GDM诊断、治疗需求或子代出生体重均无关联。
标准阈值的SMBG无法可靠地诊断减肥手术后的GDM,且可能会过度诊断GDM,尤其是胃旁路术后,尽管样本量较小限制了本研究的普遍性。减肥手术后GDM的诊断需要有替代的诊断和预后标志物。